Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Trial ID or NCT#

NCT01326390

Status

not recruiting iconNOT RECRUITING

Purpose

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Official Title

Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Patients must be affected by HCC 2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2) 3. Patients must be 18 years old or older 4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure. 5. Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
  1. 1. Subjects under the age of 18 2. Patients currently on dialysis 3. Pregnant women

Investigator(s)

Nishita Kothary, MD
Nishita Kothary, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Gloria Hwang, MD
Gloria Hwang, MD
Interventional radiologist
Clinical Professor, Radiology
David Hovsepian, MD
David Hovsepian, MD
Interventional radiologist, Radiologist
Clinical Professor, Radiology
John D. Louie, MD
John D. Louie, MD
Interventional radiologist
Clinical Professor, Radiology
Daniel Sze, MD, PhD
Daniel Sze, MD, PhD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE
WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FACR, FCIRSE
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Lawrence "Rusty" Hofmann, MD
Lawrence "Rusty" Hofmann, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)

Contact us to find out if this trial is right for you.

CONTACT

Ccto-office@stanford.edu
(650) 498-7061